兴科蓉医药(06833.HK)8月27日举行董事会会议考虑及批准中期业绩

Core Viewpoint - The company, Xingke Rong Pharmaceutical, has announced a board meeting scheduled for August 27, 2025, to consider and approve its interim results for the six months ending June 30, 2025, and to discuss the potential declaration of an interim dividend, if applicable [1] Group 1 - The board meeting will take place on August 27, 2025 [1] - The meeting will focus on the approval of interim results for the six months ending June 30, 2025 [1] - The company will also consider the proposal for an interim dividend during the meeting [1]